143 related articles for article (PubMed ID: 8858309)
1. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat.
Lorenzl S; Ködel U; Frei K; Pfister HW
Eur J Pharmacol; 1996 Jul; 308(3):335-41. PubMed ID: 8858309
[TBL] [Abstract][Full Text] [Related]
2. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
[TBL] [Abstract][Full Text] [Related]
3. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat.
Lorenzl S; Koedel U; Pfister HW
Crit Care Med; 1996 Nov; 24(11):1874-80. PubMed ID: 8917039
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis.
Koedel U; Pfister HW; Tomasz A
Brain Res; 1994 Apr; 644(1):25-31. PubMed ID: 8032946
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.
Pfister HW; Koedel U; Lorenzl S; Tomasz A
Stroke; 1992 Dec; 23(12):1798-804. PubMed ID: 1448831
[TBL] [Abstract][Full Text] [Related]
6. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
[TBL] [Abstract][Full Text] [Related]
7. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Legat FJ; Griesbacher T; Lembeck F
Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
[TBL] [Abstract][Full Text] [Related]
8. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
Félétou M; Lonchampt M; Robineau P; Jamonneau I; Thurieau C; Fauchère JL; Villa P; Ghezzi P; Prost JF; Canet E
J Pharmacol Exp Ther; 1995 Jun; 273(3):1078-84. PubMed ID: 7791078
[TBL] [Abstract][Full Text] [Related]
9. Role of bradykinin B2 receptors and mast cells in the bradykinin-induced skin response in the rat.
Morishita M; Sakamoto T; Ito K; Torii S
Eur J Pharmacol; 1996 Mar; 298(2):149-54. PubMed ID: 8867102
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic bradykinin B2 receptor blockade on blood pressure of conscious Dahl salt-resistant rats.
Mukai H; Fitzgibbon WR; Ploth DW; Margolius HS
Br J Pharmacol; 1998 May; 124(1):197-205. PubMed ID: 9630360
[TBL] [Abstract][Full Text] [Related]
11. Effect of early blockade of bradykinin B2-receptors on the blood pressure phenotype of normotensive and spontaneously hypertensive rats.
Emanueli C; Madeddu P
Pharmacol Res; 1997 Jun; 35(6):522-6. PubMed ID: 9361315
[TBL] [Abstract][Full Text] [Related]
12. The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in rats.
Buritova J; Chapman V; Honoré P; Besson JM
Eur J Pharmacol; 1997 Feb; 320(1):73-80. PubMed ID: 9049605
[TBL] [Abstract][Full Text] [Related]
13. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
Corrêa CR; Calixto JB
Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
[TBL] [Abstract][Full Text] [Related]
14. Characterization and localization of bradykinin B2 receptors in the guinea-pig using a radioiodinated HOE140 analogue.
Murone C; Perich RB; Schlawe I; Chai SY; Casley D; MacGregor DP; Müller-Esterl W; Mendelsohn FA
Eur J Pharmacol; 1996 Jun; 306(1-3):237-47. PubMed ID: 8813637
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
Yekebas E; Treede H; Jochum M; Gippner-Steppert C; Bloechle C; Knoefel WT; Scholz J; Fink E; Izbicki JR
Crit Care Med; 2000 Apr; 28(4):1119-27. PubMed ID: 10809293
[TBL] [Abstract][Full Text] [Related]
16. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis.
Pfister HW; Ködel U; Dirnagl U; Haberl RL; Ruckdeschel G; Einhäupl KM
J Infect Dis; 1992 Dec; 166(6):1442-5. PubMed ID: 1431262
[TBL] [Abstract][Full Text] [Related]
17. Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis.
Koedel U; Lorenzl S; Gorriz C; Arendt RM; Pfister HW
J Cereb Blood Flow Metab; 1998 Jan; 18(1):67-74. PubMed ID: 9428307
[TBL] [Abstract][Full Text] [Related]
18. Effects of a bradykinin receptor antagonist (HOE140) on taurocholate-induced acute pancreatitis in rats.
Kanbe T; Naruse S; Kitagawa M; Nakae Y; Hayakawa T
Pancreas; 1996 Oct; 13(3):283-8. PubMed ID: 8884850
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis.
Lorenzl S; Koedel U; Frei K; Bernatowicz A; Fontana A; Pfister HW
J Infect Dis; 1995 Jul; 172(1):113-8. PubMed ID: 7797900
[TBL] [Abstract][Full Text] [Related]
20. Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II.
Madeddu P; Parpaglia PP; Demontis MP; Varoni MV; Fattaccio MC; Glorioso N
Hypertension; 1994 May; 23(5):646-52. PubMed ID: 8175175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
